does noom semaglutide work Med Noom offers cut-price compounded GLP-1

Benzin J, Gouverneur A, Mathieu C, et al

PMID: 35389274

What does the clinical evidence say about GLP-1 and gastrointestinal side effects

Whilst the early evidence for retatrutide liver fat reduction is scientifically promising, patients are best served by working within established NHS pathways and awaiting the outcome of robust Phase 3 trial data and formal regulatory review before drawing firm conclusions about this emerging therapy

Published Phase 2 data (NEJM, 2023) showed retatrutide achieving up to 24.2% body weight reduction over 48 weeks and significant hepatic fat reduction, supporting research into obesity, NAFLD/MASH, and insulin resistance models

The patient was not treated with hormone replacement therapy and never smoked or drank alcohol